Supported by Health Professionals Bank. The results of this survey equips APNA members with information on the workforce conditions of your profession, and helps APNA’s develop evidence-based policy and programs relating to the primary health care nurse workforce and to advocate for you.
Increasing Uptake of Long-acting Reversible Contraceptives Through Nurse-Led Insertions -Kirsty Fleming
Long-acting reversible contraceptives (LARC) are highly effective in preventing pregnancy; however, uptake remains low in Australia. Extending provision by registered nurses (RNs) may increase utilisation. A cost-benefit analysis was undertaken to assess the impact of women switching from an oral contraceptive pill (OCP) to a LARC.
The additional impact of 20% of the increase in LARC insertions being undertaken by RNs was also modelled. If women switch from an OCP to a LARC, and LARC uptake increased from 12% to 14.8% (international benchmark levels), net savings are estimated at $68 million. If 20% who switch to a LARC are seen by a RN (compared to GP), there would be a government cost saving of $2.7 million.
Enabling RN-led insertions to facilitate access to LARC is a cost-effective way of improving uptake. Creating MBS item numbers for RNs trained in LARC insertion would have benefits for women and the Australian government.